Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Research graph
References from Disparities in sodium-glucose cotransporter-2 inhibitor usage between patients with and without cancer: A retrospective study. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2024 · External reference
SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
10.1016/s0140-6736(18)32590-x · 2019 · External reference
Sodium-glucose co-transporter-2 inhibitors eligibility in patients with heart failure with reduced ejection fraction
10.1016/j.ijcard.2021.08.035 · 2021 · External reference
KDIGO 2022 Clinical practice guideline for diabetes management in chronic kidney disease
2022 · External reference
SGLT2 inhibitors - the new standard of care for cardiovascular, renal and metabolic protection in type 2 diabetes: a narrative review
10.1007/s13300-024-01550-5 · 2024 · External reference
Prescribing trends of SGLT2 inhibitors among HFrEF and HFpEF patients with and without T2DM, 2013–2021
10.1186/s12872-024-03961-5 · 2024 · External reference
Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data
2024 · External reference
Uptake of SGLT2i and outcomes in patients with diabetes and heart failure: a population-based cohort and a specialized clinic cohort
10.1016/j.ahj.2024.04.007 · 2024 · External reference
Multimorbidity in people living with and beyond cancer: a scoping review
2023 · External reference
Prevalence of comorbidities and their impact on survival among older adults with the five most common cancers in Taiwan: a population study
10.1038/s41598-023-29582-0 · 2023 · External reference
Safety profile of sodium glucose co-transporter 2 (SGLT2) inhibitors: a brief summary
10.3389/fcvm.2022.1010693 · 2022 · External reference
Patients' barriers to receipt of cancer care, and factors associated with needing more assistance from a patient navigator
2011 · External reference
Financial toxicity in cancer care: implications for clinical care and potential practice solutions
10.1200/jco.22.01799 · 2023 · External reference
Barriers to healthcare access among U.S. adults with mental health challenges: a population-based study
2021 · External reference
The treatment of co-morbidities in older patients with metastatic cancer
2010 · External reference
Team-based care for cancer survivors with comorbidities: a systematic review
10.1097/jhq.0000000000000354 · 2022 · External reference